Both in Pharmaceuticals
Aptevo Therapeutics vs GRI Bio
Over the past year APVO returned −94.7% and GRI returned −96.6%; their daily moves had a correlation of 0.04.
APVO −94.7% GRI −96.6%Growth of $1, one year, split-adjusted
| Metric | APVO | GRI |
|---|---|---|
| Price | $1.34 | $1.53 |
| Market cap | $2.4M | $3.3M |
| Today | −1.47% | −2.55% |
| 1 month | −23.9% | −21.9% |
| 6 months | −72.8% | −29.8% |
| Year to date | −85.8% | −77.9% |
| 1 year | −94.8% | −96.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.8M | $10.9M |
| Dividend yield | — | — |
| Volatility (60d) | 112.9% | 134.4% |
| Short % of float | 5.8% | 3.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).